Mechanism and Regulation of Baxdelta2 in Colorectal Cancer
Mechanism and Regulation of Baxdelta2 in Colorectal Cancer
批准号:
9021169
负责人:
JIALING XIANG
金额:
$45.85万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-01-01 至 2019-12-31
关键词:
Alternative SplicingApoptoticApplications GrantsAwarenessBiomedical ResearchCASP5 geneCASP8 geneCell DeathCellsCessation of lifeCharacteristicsClinicalCodeColon CarcinomaColorectal CancerColorectal NeoplasmsDNA DamageDevelopmentDisciplineEnvironmentExonsFrameshift MutationGenesGenomicsHereditary Nonpolyposis Colorectal NeoplasmsIllinoisImageInduced MutationInstitutesLeadMalignant NeoplasmsMediatingMicrosatellite InstabilityMicrosatellite RepeatsMismatch RepairMitochondriaMolecularMutateMutationPTEN genePathway interactionsPatientsPhenotypeProtein IsoformsProteinsRegulationResearchResourcesStudentsSubgroupSystemTechnologyTherapeuticThinkingTranscriptTumor Suppressor ProteinsUniversitiesWorkanimal facilitybiological researchbiomedical facilitycancer cellcolon cancer patientsdesigneducation researchexperiencegraduate studentinnovationloss of functionneoplastic celloutcome forecastprematureprototypepublic health relevanceresearch studysensortumortumor growthtumorigenesisundergraduate student
中文摘要
英文摘要
DESCRIPTION (provided by applicant): Expression of the pro-apoptotic tumor suppressor Bax can be silenced by frameshift mutations in its microsatellite coding region, leading to a Bax-negative phenotype. Such Bax mutations occur in ~50% of hereditary nonpolyposis colorectal cancer (HNPCC) due to deficiency of mismatch repair system associated microsatellite instability (MSI). Loss of Bax has been demonstrated to increase chemoresistance and is associated with poor prognosis. Recently, we found that some "Bax-negative" tumor cells actually contain a functional Bax isoform, BaxΔ2, which is generated when alternative splicing corrects the mutation-induced frameshift. Therefore, BaxΔ2 only exists in microsatellite-mutated cells. We have demonstrated that this "salvaged" Bax∆2 is pro-death, similar to prototype Bax, but induce cell death potential through a non- mitochondrial death pathway. Importantly, colon cancer cells expressing Bax∆2 are more sensitive to selected chemotherapeutics. Therefore, we hypothesize that BaxΔ2 determines tumor malignant potential and chemotherapeutic selectivity in "Bax-negative" MSI colorectal cancer cells through a non-canonical Bax- death pathway. We have two specific aims: 1) to study the mechanism underlying Bax∆2-mediated cell death; and 2) to identify key regulators responsible for controlling Bax∆2 expression levels
in MSI colorectal tumor cells. Since there was no awareness of the existence of a Bax isoform in the "Bax-negative" cancer prior to this study, we think the studies proposed in this grant application are conceptually innovative and significant because they will change the current paradigm for understanding the development and prognosis of the "Bax-negative" MSI colorectal cancer and facilitating selection of specific chemotherapeutics for this subgroup of "Bax-negative" colon cancer patients. The Illinois Institute of Technology (IIT) is a private university with a wide range of academic disciplines. The University encourages biological research and promotes integrative biomedical research with potential translational impact. IIT currently lacks several biomedical facilities, such as high-level genomic and imaging facilities, a
full-featured animal facility, and clinical resources. However, IIT does have a large body of undergraduate and graduate students eager to participate in biomedical research. The PI has a strong academic credential for both education and research. The proposed project is carefully designed to exploit the strengths of IIT's research environment and maximize opportunities for student hands-on research experiences. Successful completion of the proposed studies will have a substantial positive impact on IIT's biomedical research capacity.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.bbrc.2018.08.123
发表时间:
2018-09-18
期刊:
Biochemical and biophysical research communications
影响因子:
3.1
作者:
[Yao Q, Zhang H, Zhao Y, Ye Z, Lee YJ, Xiang J]
通讯作者:
Xiang J
DOI:
10.1016/j.bbrc.2017.12.156
发表时间:
2018-01-29
期刊:
Biochemical and biophysical research communications
影响因子:
3.1
作者:
[Mañas A, Chen W, Nelson A, Yao Q, Xiang J]
通讯作者:
Xiang J
Differentially Regulating Apoptosis by AR: Activating Bax or Inhibiting JNK MAPK
-
批准号:8050583
-
项目类别:
-
资助金额:$29.57万
-
财政年份:2008
-
负责人:JIALING XIANG
-
依托单位:
Differentially Regulating Apoptosis by AR: Activating Bax or Inhibiting JNK MAPK
-
批准号:8247109
-
项目类别:
-
资助金额:$29.88万
-
财政年份:2008
-
负责人:JIALING XIANG
-
依托单位:
Differentially Regulating Apoptosis by AR: Activating Bax or Inhibiting JNK MAPK
-
批准号:7382872
-
项目类别:
-
资助金额:$30.54万
-
财政年份:2008
-
负责人:JIALING XIANG
-
依托单位:
Differentially Regulating Apoptosis by AR: Activating Bax or Inhibiting JNK MAPK
-
批准号:7568765
-
项目类别:
-
资助金额:$30.53万
-
财政年份:2008
-
负责人:JIALING XIANG
-
依托单位:
Differentially Regulating Apoptosis by AR: Activating Bax or Inhibiting JNK MAPK
-
批准号:7810533
-
项目类别:
-
资助金额:$30.08万
-
财政年份:2008
-
负责人:JIALING XIANG
-
依托单位:
Prostate Cancer--Mechanisms of Bax induced Cell Death
-
批准号:6937837
-
项目类别:
-
资助金额:$10.54万
-
财政年份:2001
-
负责人:JIALING XIANG
-
依托单位:
Prostate Cancer--Mechanisms of Bax induced Cell Death
-
批准号:6630465
-
项目类别:
-
资助金额:$10.12万
-
财政年份:2001
-
负责人:JIALING XIANG
-
依托单位:
Prostate Cancer--Mechanisms of Bax induced Cell Death
-
批准号:6522658
-
项目类别:
-
资助金额:$9.92万
-
财政年份:2001
-
负责人:JIALING XIANG
-
依托单位:
Prostate Cancer--Mechanisms of Bax induced Cell Death
-
批准号:6805135
-
项目类别:
-
资助金额:$10.33万
-
财政年份:2001
-
负责人:JIALING XIANG
-
依托单位:
Prostate Cancer--Mechanisms of Bax induced Cell Death
-
批准号:6321266
-
项目类别:
-
资助金额:$9.73万
-
财政年份:2001
-
负责人:JIALING XIANG
-
依托单位:
海外基金